Frontiers In Real-World Evidence: US FDA Partners With Syapse To Explore Sources Beyond Electronic Records

Oncology Center of Excellence will collaborate with the health data company to explore RWE sources for precision medicine.

Treasure Chest Map_1200 — US FDA and PCORI are working with data companies to support more use and sharing of real-world and other data, potentially for drug development. • Source: Shutterstock

The US Food and Drug Administration will work with Syapse Inc. to develop new real-world evidence sources outside electronic health records for various regulatory purposes.

FDA's Oncology Center of Excellence and Syapse announced a new four-year partnership on 14 August for real-world evidence (RWE) development...

Frontiers In Real-World Evidence: US FDA Partners With Syapse To Explore Sources Beyond Electronic Records

More from Real-World Evidence

More from Clinical Trials